The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies

被引：39

作者：

Cataland, Spero R. ^{[1
]}

Yang, Shangbin ^{[2
]}

Wu, Haifeng M. ^{[2
]}

机构：

[1] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA

[2] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 157卷 / 04期

关键词：

aHUS; TTP; ADAMTS13; platelet count; creatinine; CLEAVING PROTEASE ADAMTS13; DEFICIENCY;

D O I：

10.1111/j.1365-2141.2012.09032.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：501 / 503

页数：3

共 10 条

[1] Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders:: a severely deficient activity is specific for thrombotic thrombocytopenic purpura [J].

Bianchi, V ;

Robles, R ;

Alberio, L ;

Furlan, M ;

Lämmle, B .

BLOOD, 2002, 100 (02) :710-713

[2] Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement [J].

Coppo, P ;

Bengoufa, D ;

Veyradier, A ;

Wolf, M ;

Bussel, A ;

Millot, GA ;

Malot, S ;

Heshmati, F ;

Mira, JP ;

Boulanger, E ;

Galicier, L ;

Durey-Dragon, MA ;

Frémeaux-Bacchi, V ;

Ramakers, M ;

Pruna, A ;

Bordessoule, D ;

Gouilleux, V ;

Scrobohaci, ML ;

Vernant, JP ;

Moreau, D ;

Azoulay, E ;

Schlemmer, B ;

Guillevin, L ;

Lassoued, K .

MEDICINE, 2004, 83 (04) :233-244

[3] Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura [J].

Froehlich-Zahnd, Rahel ;

George, James N. ;

Vesely, Sara K. ;

Terrell, Deirdra R. ;

Aboulfatova, Khatira ;

Dong, Jing-Fei ;

Luken, Brenda M. ;

Voorberg, Jan ;

Budde, Ulrich ;

Sulzer, Irmela ;

Laemmle, Bernhard ;

Hovinga, Johanna A. Kremer .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (02) :297-303

[4] Survival and relapse in patients with thrombotic thrombocytopenic purpura [J].

Hovinga, Johanna A. Kremer ;

Vesely, Sara K. ;

Terrell, Deirdra R. ;

Laemmle, Bernhard ;

George, James N. .

BLOOD, 2010, 115 (08) :1500-1511

[5]

Legendre C. M., 2010, J AM SOC NEPHROL, V21, p93A

[6] Complement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome [J].

Mache, Christoph J. ;

Acham-Roschitz, Birgit ;

Fremeaux-Bacchi, Veronique ;

Kirschfink, Michael ;

Zipfel, Peter F. ;

Roedl, Siegfried ;

Vester, Udo ;

Ring, Ekkehard .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (08) :1312-1316

[7] Is ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? No [J].

Remuzzi, G .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (04) :632-634

[8] von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome [J].

Remuzzi, G ;

Galbusera, M ;

Noris, M ;

Canciani, MT ;

Daina, E ;

Bresin, E ;

Contaretti, S ;

Caprioli, J ;

Gamba, S ;

Ruggenenti, P ;

Perico, N ;

Mannucci, PM .

BLOOD, 2002, 100 (03) :778-785

[9] Mutations in Complement Regulatory Proteins Predispose to Preeclampsia: A Genetic Analysis of the PROMISSE Cohort [J].

Salmon, Jane E. ;

Heuser, Cara ;

Triebwasser, Michael ;

Liszewski, M. Kathryn ;

Kavanagh, David ;

Roumenina, Lubka ;

Branch, D. Ware ;

Goodship, Tim ;

Fremeaux-Bacchi, Veronique ;

Atkinson, John P. .

PLOS MEDICINE, 2011, 8 (03)

[10] Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes [J].

Tsai, HM .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (04) :625-631

← 1 →